I'm a little confused by the content of your post. Your arguments are based on the earnings of the company and how they are failing to extract operating leverage with revenue growth. This tells me that your taking a fundamental view of the company, but then you talk about being a willing buyer at a price only 6% lower, despite the stated concerns.
I know that in my case, if I was convinced that the company could not drive earnings higher going forward, while trading on an elevated PE , that I would want a much bigger fall than 6% from my sell price to get re-interested.
Ann: ResMed Announces Results for the Second Qtr of FY 2017, page-11
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$37.28 |
Change
0.200(0.54%) |
Mkt cap ! $22.38B | |||
| Open | High | Low | Value | Volume |
| $37.50 | $37.55 | $37.15 | $17.93M | 480.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3363 | $37.27 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $37.30 | 1001 | 2 |
View Market Depth
| Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
| RMD (ASX) Chart |
